This quality improvement study compares outcomes among high-risk Native American patients who did or did not receive monoclonal antibody treatment for COVID-19.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456379 | PMC |
| http://dx.doi.org/10.1001/jamanetworkopen.2021.25866 | DOI Listing |
Publication Analysis
Top Keywords
high-risk native
8
native american
8
american patients
8
patients receive
8
receive monoclonal
8
monoclonal antibody
8
antibody treatment
8
treatment covid-19
8
outcome comparison
4
comparison high-risk
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!